Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shinkyo Yoon

Showing results (11-20 of 88) with videos related to

Pageof 9
Sort By:
Journal of Pathology and Translational Medicine|August 2, 2021
Primary hepatic mixed germ cell tumor in an adultHyun-Jung Sung, Jihun Kim, Kyu-Rae Kim, et al.
Cancer Imaging : the Official Publication of the International Cancer Imaging Society|October 24, 2023
Prognostic value of MRI volumetric parameters in non-small cell lung cancer patients after immune checkpoint inhibitor therapy: comparison with response assessment criteriaYun Hwa Roh, Ji Eun Park, Sora Kang, et al.
Radiology|August 5, 2020
Incidence of Pseudoprogression during Immune Checkpoint Inhibitor Therapy for Solid Tumors: A Systematic Review and Meta-AnalysisHyo Jung Park, Kyung Won Kim, Junhee Pyo, et al.
Cancer Medicine|May 7, 2021
Real-world utility of next-generation sequencing for targeted gene analysis and its application to treatment in lung adenocarcinomaJwa Hoon Kim, Shinkyo Yoon, Dae Ho Lee, et al.
Clinical Genitourinary Cancer|January 16, 2024
Outcomes of systemic treatment according to germline mutational status in patients with metastatic pheochromocytoma and paragangliomaYoung-Gyu Park, Inkeun Park, Yongjae Kim, et al.
Cancer Research and Treatment|January 31, 2024
Comparison of Clinicopathogenomic Features and Treatment Outcomes of EGFR and HER2 Exon 20 Insertion Mutations in Non-Small Cell Lung Cancer: Single-Institution ExperienceSo Heun Lee, Hyehyun Jeong, Deok Hoon Kim, et al.
Translational Lung Cancer Research|October 17, 2022
Impact of gender on response to immune checkpoint inhibitors in patients with non-small cell lung cancer undergoing second- or later-line treatmentMyeong Geun Choi, Chang-Min Choi, Dae Ho Lee, et al.
Leukemia & Lymphoma|June 11, 2014
Prognostic impact of β₂-microglobulin in patients with non-gastric mucosa-associated lymphoid tissue lymphomaChanghoon Yoo, Dok Hyun Yoon, Shinkyo Yoon, et al.
Cancer Chemotherapy and Pharmacology|December 10, 2014
A Phase I study of cabazitaxel in patients with advanced gastric cancer who have failed prior chemotherapy (GASTANA)Yoon-Koo Kang, Baek-Yeol Ryoo, Shinkyo Yoon, et al.
Journal of Cancer Research and Clinical Oncology|May 31, 2019
Exceptional pemetrexed sensitivity can predict therapeutic benefit from subsequent chemotherapy in metastatic non-squamous non-small cell lung cancerJi Hyun Park, Byoung Soo Kwon, So Jung Park, et al.
Pageof 9

Showing results (11-20 of 88) with videos related to

Sort By:
Pageof 9
Journal of Pathology and Translational Medicine|August 2, 2021
Primary hepatic mixed germ cell tumor in an adultHyun-Jung Sung, Jihun Kim, Kyu-Rae Kim, et al.
Cancer Imaging : the Official Publication of the International Cancer Imaging Society|October 24, 2023
Prognostic value of MRI volumetric parameters in non-small cell lung cancer patients after immune checkpoint inhibitor therapy: comparison with response assessment criteriaYun Hwa Roh, Ji Eun Park, Sora Kang, et al.
Radiology|August 5, 2020
Incidence of Pseudoprogression during Immune Checkpoint Inhibitor Therapy for Solid Tumors: A Systematic Review and Meta-AnalysisHyo Jung Park, Kyung Won Kim, Junhee Pyo, et al.
Cancer Medicine|May 7, 2021
Real-world utility of next-generation sequencing for targeted gene analysis and its application to treatment in lung adenocarcinomaJwa Hoon Kim, Shinkyo Yoon, Dae Ho Lee, et al.
Clinical Genitourinary Cancer|January 16, 2024
Outcomes of systemic treatment according to germline mutational status in patients with metastatic pheochromocytoma and paragangliomaYoung-Gyu Park, Inkeun Park, Yongjae Kim, et al.
Cancer Research and Treatment|January 31, 2024
Comparison of Clinicopathogenomic Features and Treatment Outcomes of EGFR and HER2 Exon 20 Insertion Mutations in Non-Small Cell Lung Cancer: Single-Institution ExperienceSo Heun Lee, Hyehyun Jeong, Deok Hoon Kim, et al.
Translational Lung Cancer Research|October 17, 2022
Impact of gender on response to immune checkpoint inhibitors in patients with non-small cell lung cancer undergoing second- or later-line treatmentMyeong Geun Choi, Chang-Min Choi, Dae Ho Lee, et al.
Leukemia & Lymphoma|June 11, 2014
Prognostic impact of β₂-microglobulin in patients with non-gastric mucosa-associated lymphoid tissue lymphomaChanghoon Yoo, Dok Hyun Yoon, Shinkyo Yoon, et al.
Cancer Chemotherapy and Pharmacology|December 10, 2014
A Phase I study of cabazitaxel in patients with advanced gastric cancer who have failed prior chemotherapy (GASTANA)Yoon-Koo Kang, Baek-Yeol Ryoo, Shinkyo Yoon, et al.
Journal of Cancer Research and Clinical Oncology|May 31, 2019
Exceptional pemetrexed sensitivity can predict therapeutic benefit from subsequent chemotherapy in metastatic non-squamous non-small cell lung cancerJi Hyun Park, Byoung Soo Kwon, So Jung Park, et al.
Pageof 9